Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Q: What does CUSIP 221015100 represent in this 13F holders report?

CUSIP 221015100 is the security identifier for CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q3 2016?

44 institutional investors reported CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q3 2016. Use the holders table for investor-level position and value details.

CUSIP: 221015100

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 91,091,040
Total 13F shares: 16,266,787
Share change: -1,066,852
Total reported value: $267,555,203
Price per share: $16.45
Number of holders: 44
Value change: -$17,049,726
Number of buys: 20
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 221015100?
CUSIP 221015100 identifies CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2016
Previous quarter: Q2 2016

Recent filing periods for CUSIP 221015100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	5.9%	5,379,349	$76,710,000	—	30 Jun 2016	13F
Novo Holdings A/S	13F	Company	3.5%	3,224,046	$45,975,000	—	30 Jun 2016	13F
FMR LLC	13F	Company	2.5%	2,311,297	$32,959,000	—	30 Jun 2016	13F
ADAMS STREET PARTNERS LLC	13F	Company	3%	2,687,381	$28,742,000	—	30 Jun 2016	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.7%	634,888	$8,799,000	—	30 Jun 2016	13F
JENNISON ASSOCIATES LLC	13F	Company	0.63%	570,481	$8,067,000	—	30 Jun 2016	13F
BLACKROCK ADVISORS LLC	13F	Company	0.5%	456,117	$6,504,000	—	30 Jun 2016	13F
Rock Springs Capital Management LP	13F	Company	0.49%	450,000	$6,417,000	—	30 Jun 2016	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.36%	325,053	$4,577,000	—	30 Jun 2016	13F
Cormorant Asset Management, LP	13F	Company	0.24%	214,132	$3,054,000	—	30 Jun 2016	13F
Alyeska Investment Group, L.P.	13F	Company	0.22%	200,873	$2,864,000	—	30 Jun 2016	13F
JPMORGAN CHASE & CO	13F	Company	0.19%	175,100	$2,497,000	—	30 Jun 2016	13F
VANGUARD GROUP INC	13F	Company	0.18%	166,797	$2,378,000	—	30 Jun 2016	13F
Allianz Asset Management GmbH	13F	Company	0.14%	125,000	$1,783,000	—	30 Jun 2016	13F
BlackRock Fund Advisors	13F	Company	0.1%	87,541	$1,248,000	—	30 Jun 2016	13F
Avoro Capital Advisors LLC	13F	Company	0.08%	74,800	$1,067,000	—	30 Jun 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.04%	35,734	$510,000	—	30 Jun 2016	13F
NORTHERN TRUST CORP	13F	Company	0.03%	31,527	$450,000	—	30 Jun 2016	13F
STATE STREET CORP	13F	Company	0.03%	28,595	$407,000	—	30 Jun 2016	13F
Nationwide Fund Advisors	13F	Company	0.03%	27,057	$386,000	—	30 Jun 2016	13F
Emerald Acquisition Ltd.	13F	Company	0.02%	21,615	$308,000	—	30 Jun 2016	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.02%	20,000	$285,000	—	30 Jun 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	17,361	$248,000	—	30 Jun 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.01%	12,394	$177,000	—	30 Jun 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.01%	11,010	$157,000	—	30 Jun 2016	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	7,500	$107,000	—	30 Jun 2016	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	6,967	$99,000	—	30 Jun 2016	13F
BlackRock Group LTD	13F	Company	0.01%	5,062	$72,000	—	30 Jun 2016	13F
NORGES BANK	13F	Company	0%	4,200	$60,000	—	30 Jun 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0%	3,551	$51,000	—	30 Jun 2016	13F
DEUTSCHE BANK AG\	13F	Company	0%	3,460	$49,000	—	30 Jun 2016	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	3,455	$49,000	—	30 Jun 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	2,259	$32,000	—	30 Jun 2016	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	1,913	$27,279	—	30 Jun 2016	13F
UBS Group AG	13F	Company	0%	1,419	$20,000	—	30 Jun 2016	13F
CITIGROUP INC	13F	Company	0%	1,330	$19,000	—	30 Jun 2016	13F
STRS OHIO	13F	Company	0%	1,100	$15,000	—	30 Jun 2016	13F
BlackRock Japan Co. Ltd	13F	Company	0%	835	$12,000	—	30 Jun 2016	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	700	$10,000	—	30 Jun 2016	13F
Cable Hill Partners, LLC	13F	Company	0%	400	$6,000	—	30 Jun 2016	13F
BlackRock Finance, Inc.	13F	Company	0%	200	$3,000	—	30 Jun 2016	13F
Catalyst Capital Advisors LLC	13F	Company	0%	165	$2,000	—	30 Jun 2016	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0%	159	$2,000	—	30 Jun 2016	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	111	$2,000	—	30 Jun 2016	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	131	$1,868	—	30 Jun 2016	13F

Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q3 2016

As of 30 Sep 2016, Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,266,787 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Novo A/S, ADAMS STREET PARTNERS LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, JENNISON ASSOCIATES LLC, BlackRock Advisors LLC, Rock Springs Capital Management LP, SPHERA FUNDS MANAGEMENT LTD., and venBio Select Advisor LLC. This page lists 44 institutional shareholders reporting positions in this security for the Q3 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders

Q3 2016 holders

Holder diff

Investor	Q2 2016 Shares	Q3 2016 Shares	Share Diff	Share Chg %	Q2 2016 Value $	Q3 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.